Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamidol 0.15% with hyaluronic acid vs Thiamidol or hyaluronic acid alone for melasma (randomized single-blind)
TCTR20200710001Phase 1Recruiting
- Sponsor
- Faculty of Medicine, Thammasat University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in melasma comparing Thiamidol 0.15% + hyaluronic acid, Thiamidol 0.15% alone and Hyaluronic acid alone (3 arms). Primary endpoints: Efficacy for melasma and Safety and tolerability. Started Sep 2019; status: recruiting.
02
Drugs
thiamidolhyaluronic acid
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20200710001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200710001.